A Comparative Study of Split Thickness Skin Graft (STSG) With Jalaukavacharana and without Jalaukavacharana in the Management of Dushta Vrana (Chronic Non- Healing Ulcer)
Main Article Content
Abstract
Background: Ulcer is the break in the continuity of covering epithelium either skin or mucous membrane. In Ayurveda it is described as Vrana. Jalaukavacharna is type of Raktamokashana. Split thickness skin Grafting is the type of skin grafting.
Aims and Objectives: To Assess and compare the effect of Jalaukavcharna in acceptance of STSG in both groups with changes obtained in Pre decided criteria.
Material and Method: It was randomized, open labeled clinical study. Total enrolled 30 patients were equally divided in two groups. In Group A pre treatment of Jalaukavacharna done for 5 days and then STSG procedure done. In Group B only STSG done.
Observation and Results: Signed rank test suggest that there is highly significant difference in Adherence of STSG, Discharge and Color (p<0.001), But no significant difference in Graft edema (p =1.00) and Foul smell (p=0.5) in Group A. There is highly significant difference in Adherence of STSG, Discharge and Color (p<0.001), But no significant difference in Graft edema (p =0.5) and Foul smell (p=0.5) in Group B. Mann Whitney U test suggest that there is no significance difference between two groups.
Discussion: Pre-treatment of Jalaukavacharana before STSG is not more effective in acceptance of STSG than only STSG without pre-treatment of Jalaukavacharana in the surgical management of Dushtavrana.
Conclusion: Split Thickness Skin Graft with Jalaukavacharna is not beneficial statically.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. SRB’s Clinical methods in surgery; by Sriram Bhat M; second edition; Jaypee publications; chapter 3;p.70
II. Non healing wounds ; American college of surgeons divison of education blended surgical education and training for life;
https://www.facs.org/-/media/files/education/core-curriculum/nonhealing_wounds.ashx
III. Sushruta, Sushruta Samhita, Chikitsasthana, chapter 1, verse 6, Hindi translated by Shri. Ambika Dutta Shastri. Varanasi: Chaukhambha Sanskrit Sansthan; Reprint 2014. P. 4
IV. Sushruta, Sushruta Samhita, Sutrasthan, chapter 14 , Hindi translated by acharya P V Sharma Vol.1; 2013 p.100;112
V. Sushruta, Sushruta Samhita, Sutrasthan, chapter 13, verse 11 ;Jalaukavacharaniyaadhyaya, Hindi translated by Acharya P V Sharma Vol.1; 2013 p.95
VI. Jalauka (Leech) Application with Splits Thickness Skin Graft (Stsg) On Chronic Non-Healing Ulcer-A Case Study Dr. Vaghasiya C. S. And Dr. Shah H. S. ; European Journal Of Biomedical And Pharmaceutical Science: Issn 2349-8870 Vol 5 Issue 1 ,750-754 ,Year 2018
VII. Sarvesh Kumar Singh, KshipraRajoria,Medical leech therapy in Ayurveda and biomedicine – A review, Journal of Ayurveda and Integrative Medicine,2019,ISSN 0975-9476
VIII. Deganc M, Zdravic F. Venous congestion of flaps treated by application of leeches. British Journal of Plastic Surgery. 1960;13:187–192. [PubMed] [Google Scholar]
IX. Michalsen A, Roth M, Dobos G. Medicinal Leech Therapy. New York, NY, USA: Georg Thieme; 2007.
X. Grassberger M, Sherman RA, Gileva O, Kim CMH, Mumcuoglu KY, editors. Biotherapy—History, Principles and Practice: A Practical Guide to the Diagnosis and Treatment of Disease Using Living Organisms. Heidelberg, Germany: Springer; 2013.
XI. Recommendations for the Use of Leeches in the Reconstructive Plastic Surgery Kosta Y. Mumcuoglu , Published online 2014 Feb 6. doi: 10.1155/2014/205929
XII. Whitaker IS, Izadi D, Oliver DW, Monteath G, Butler PE. Hirudo medicinalis and the plastic surgeon. British Journal of Plastic Surgery. 2004;57(4):348–353.
XIII. Eldor A, Orevi M, Rigbi M. The role of the leech in medical therapeutics. Blood Reviews. 1996;10(4):201–209.
XIV. Siddall ME, Trontelj P, Utevsky SY, Nkamany M, Macdonald KS., III Diverse molecular data demonstrate that commercially available medicinal leeches are not Hirudo medicinalis . Proceedings of the Royal Society B. 2007;274(1617):1481–1487.
XV. Rigbi M, Orevi M, Eldor A. Platelet aggregation and coagulation inhibitors in leech saliva and their roles in leech therapy. Seminars in Thrombosis and Hemostasis. 1996;22(3):273–278.
XVI. 46. Fritz H, Oppitz KH, Gebhardt M, Oppitz I, Werle E, Marx R. On the presence of a trypsin-plasmin inhibitor in hirudin. Hoppe-Seyler’s Zeitschrift fur Physiologische Chemie. 1969;350(1):91–92.
XVII. 47. Seemueller U, Meier M, Ohlsson K, Müller HP, Fritz H. Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocytic elastase and cathepsin G) from leeches. Hoppe-Seyler’s Zeitschrift fur Physiologische Chemie. 1977;358(9):1105–1117.
XVIII. Seemuller U, Dodt J, Fink E, et al. Proteinase inhibitors of the leech Hirudo medicinalis (hirudins, bdellins, eglins) In: Barettand AJ, Salvesen G, editors. Proteinase Inhibitors. New York, NY, USA: Elsevier; 1986. pp. 337–359.
XIX. 49. Sollner C, Mentele R, Eckerskorn C, Fritz H, Sommerhoff CP. Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leech Hirudo medicinalis. European Journal of Biochemistry. 1994;219(3):937–943.
XX. Baskova IP, Khalil S, Nartikova VF, Paskhina TS. Inhibition of plasma kallikrein, kininase and kinin-like activities of preparations from the medicinal leeches. Thrombosis Research. 1992;67(6):721–730.
XXI. Hovingh P, Linker A. Hyaluronidase activity in leeches (Hirudinea) Comparative Biochemistry and Physiology B. 1999;124(3):319–326.
XXII. Gileva OS, Mumcuoglu KY. Hirudotherapy. In: Grassberger M, Sherman RA, Gileva O, Kim CMH, Mumcuoglu KY, editors. Biotherapy—History, Principles and Practice: A Practical Guide to the Diagnosis and Treatment of Disease Using Living Organisms. Heidelberg, Germany: Springer; 2013. pp. 31–76.